To continue using FE Trustnet please choose an edition:

This site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about cookies on the website and how to delete cookies, see our Privacy and Cookie Policy.

I accept the FE Trustnet cookie policy

For more information Click here

Login

Login

Register

It's look like you're leaving us

What would you like us to do with the funds you've selected

Show me all my options Forget them Save them
Customise this table
 
 
Poll

What is the best asset class to protect investors from equity risk?

Bonds
Absolute return strategies
Property
Commodities

Vote

 
You are here: Factsheet

Contact details

ManagerGroupLogo
Frostrow Capital LLP, 25 Southampton Buildings, London, WC2A 1AL
0203 043 8889 (Fax Number)
0203 008 4910 (Main Number)

info@frostrow.com

Fund managers

* Samuel D Isaly»01-Apr-1995 to Present
* Sven H Borho»01-Apr-1995 to Present


Investment objectives

To invest in the global healthcare sector with the objective of achieving a high level of capital growth. In order to achieve its investment objective, the Company invests worldwide in a diversified portfolio of shares in pharmaceutical and biotechnology companies and related securities in the healthcare sector. It uses gearing and derivative transactions to mitigate risk and also to enhance returns.

Key Information

Fund vs sector

  1y 3y
Position 2 / 4 3 / 4
Quartile 2 3

Fund ratings

FE Crown Rating: 3 FE
Crown Rating
(Quantitative)

Ratios

  1y 3y
Volatility 18.33 13.64
Alpha 13.72 7.08
Beta 0.81 0.80
Sharpe 2.01 2.45
InfoRatio 0.80 0.10
R2 0.76 0.76
Quartiles:   1  2   3  4   help with ratios
vs. Biotechnology & Healthcare»

Performance

performance chart
chart
    1y 3y 5y 12m-24m 24m-36m 36m-48m 48m-60m
+42.8 +157.8 +225.5 +45.9 +23.7 +3.4 +22.1
  NAV +35.5+136.6+193.6+43.6 +21.7+3.3+20.1
  Biotechnology & Healthcare +37.5+159.3+228.0+41.2+33.6+6.4+18.9
Share Price
 SharePriceDatePrem/DiscDiluted NAVGearingDiv yield
EstimLast pub.NetGross
pdf WORLDWIDE HEALTHCARE TRUST PLC ORD 1674.00 (p) 21-Nov-2014 -2.33 1714.88 1707.58
20-Nov-2014
111 0.84 0.84
Capital structure & income
Share Type Exchange Nominal value Issued Market value (m) Wind-up date Splits News
WORLDWIDE HEALTHCARE TRUST PLC ORD UNIT LONDON 25 48,097,000 805.62 n/a n/a company announcements
Share identifiers: TIDM: WWH; SEDOL: 0338530; ISIN: GB0003385308
Detailed fund information
Fund type flag United Kingdom-registered Investment Trusts
Launched1995
Gross assets£916.2m / $1,436.5m
Sector Biotechnology & Healthcare
Asset ClassEquity
Own ISA wrapper Fund has ISA Wrapper help with ISA
Savings plan Fund has Savings Plan Minimum: £ 100.0 Monthly
Annual accountsn/a
Last report / accounts06-Jun-2014
Last AGM29-Jul-2013
Next AGMJuly 2013
EGM14-Jul-2014
Stockbroker(s)Winterflood Investment Trusts
Management contractFrostrow Capital LLP receives a periodic fee equal to 0.30% p.a. of the Company's market capitalisation up to GBP 150 million of such market capitalisation and 0.20% per annum on market capitalisation in excess of GBP 150 million plus a fixed amount equal to GBP 50,000 p.a. Investment Manager is also entitled to the payment of a performance fee. The performance fee amounts to 16.5% of any out-performance of the NAV over the benchmark index. At each quarterly calculation date any performance fee payable is based on the lower of: (i) the cumulative out-performance of the investment portfolio over the benchmark index as at the quarter end date; and (ii) the cumulative out-performance of the investment portfolio over the benchmark as at the corresponding quarter end date in the previous year.
Borrowing limitn/a
Continuation / Wind-up provisionContinuation vote passed at the AGM in 2009 and will be proposed at every fifth AGM thereafter. Fund may make market purchases of up to 14.99% of its issued share capital; this authority has to be renewed on an annual basis. If at any point the discount rises above 5% the Company has the authority to start making purchases in order to try and keep the discount below or around this level. The Fund has the authority to only resell Treasury Shares at lower discount than purchased and only at a 5% discount or less.
Dividend policyn/a
Investment restrictionsn/a
Reconstruction proposaln/a
Settlement detailsn/a
Tax policyn/a
Peer groups
Region Asset Class Investment Focus Sector
Global Equity Biotech Biotechnology & Healthcare
Largest holdings, 30-Sep-2014
Holding (%) Rank Holding (%) Rank
HCA HLDGS INC4.001MERCK & CO INC(NEW)3.406
ROCHE HLDG AG4.002AMGEN INC3.307
ABBVIE INC3.903ACTAVIS PLC2.808
REGENERON PHARMACEUTICALS INC3.704BIOGEN IDEC INC2.809
BRISTOL-MYERS SQUIBB CO3.705ONO PHARMACEUTICAL CO2.6010
 Total34.20 
Regional weightings, 30-Sep-2014
Region (%) Rank  
North America 66.40 1 66.40% North America
Europe 16.50 2 16.50% Europe
Global Emerging Markets 10.10 3 10.10% Global Emerging Markets
Asia 7.00 4 7.00% Asia
Total100.00 
Sector weightings, 30-Sep-2014
Sector (%) Rank  
Large Cap Companies 71.90 1 71.90% Large Cap Companies
Small Cap Companies 28.10 2 28.10% Small Cap Companies
Total100.00 


All prices in Pence Sterling (GBX) unless otherwise specified. Price total return performance figures are calculated using closing mid prices and with net income (dividends) reinvested. NAV total return performance figures are calculated using fully diluted (where applicable) daily estimated NAV figures from Thomson Financial Datastream and with gross income (dividends) reinvested.

 
 
Sign up for email alerts
Stay upto date on the latest fund research from FE
 
subscribe Readers of this page also looked at:
alter Polar Cap Tech Tst PLC
alter The Biotech Growth Trust PLC
 
 
 
Add your comment
 
Reload Change mode
 
Enter the words above:
Send comment
 
Allan Solomon Jul 24th, 2010 at 04:25 PM

Is this related to Finsbury Worldwide Pharmaceutical Trust ?

Reply
Allan Solomon Dec 10th, 2009 at 03:56 PM

Nothing about Subscription Shares here.

Reply
 

Back to top of page

Downloads

Asset allocation

North American Equities, 66.40%
66.4000% ofNorth American Equities
European Equities, 16.50%
16.5000% ofEuropean Equities
Global Emerging Market Equities, 10.10%
10.1000% ofGlobal Emerging Market Equities
Asia Pacific Equities, 7.00%
7.0000% ofAsia Pacific Equities

Sector analysis

Charting

FE Trustnet portfolio

register   login
Register     Login
Use the plus sign add to portfolio on the left to add this fund to your portfolio